RxDoctor Payments Data

Michael Chang, DO

Pain Medicine · Walnut Creek, CANPI 1205934262

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for pain medicine clinicians in CA, where the typical reported total is $1,829.

$1,580in general payments, 2019–2025

Across 32 payments — averaging $49.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$290
  • Saluda Medical Americas, Inc.$273
  • Boston Scientific$220
  • Si-bone, Inc.$214
  • Vertos Medical, Inc.$150
  • Nevro Corp.$139
  • plus $294 from 8 others
$1,766in research payments, 2019–2025

Across 4 payments — averaging $441.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$2K
  • Saluda Medical Americas, Inc.$16

What the payments were for

  • Food & beverage$1,580100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,580 in reported general payments places this provider in the 45th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Medicare billing

Part B allowed, 2024
$526,256
Medicare patients
1,080
Services billed
3,967

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen146$1,010
Gabapentin79$989
Celecoxib22$588
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$182
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$100
Ibuprofen17$92
Methylprednisolone13$56
Tramadol Hcl13$56
Cyclobenzaprine Hcl13$50
Diazepam32$27
Meloxicam19$18

Paid to pharmacies, not to this prescriber.

Other pain medicine in Walnut Creek

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →